Wait a second!
More handpicked essays just for you.
More handpicked essays just for you.
Essay on opioid crisis
Thesis statement for opioid crisis paper
Opioid crisis thesis statement
Don’t take our word for it - see why 10 million students trust us with their essay needs.
Recommended: Essay on opioid crisis
The 750$ Pill Response There is much to be done if the current pharmaceutical industry is to be put in check. Currently, they are essentially allowed to do whatever they wish, as there are almost no regulations on how they price medications. Clinical trials are buried if they don’t show positive results, and people have died as a result. Legislation has been proposed to change this system, but the pharmaceutical industry wields even more power than the NRA in terms of influencing politics. For this to change, politicians would have to be courageous and pass laws to regulate this currently indomitable force. The largest issue is that pharmaceutical companies have a “blank check” from consumers, and for this to change an outside force must
be created to regulate the price of medications. Preferably, a board of health care professionals and financial lawyers could be created to ensure that companies can’t arbitrarily change prices solely to gain profit. Together, they could come to a compromise on an ideal price that benefits all parties involved. Pharmaceutical companies must also not be allowed to fund and conduct studies on their own medications, as it has become clear that they are willing to conceal the results of studies or pay off reviewers in order to make a profit. For example, the fact that the drug Avandia raises “bad” cholesterol levels was discovered in an internal study, and instead of removing the drug from the market GlaxoSmithKline hid the results. As a result, up to 100,000 people suffered heart attacks. These corporations have run unchecked for too long, and it’s time that something is done about them before more people are harmed or killed.
Med-Pharmex Incorporated is known nationally and abroad as a pharmaceutical manufacturer of animal-related products. Before gaining fame worldwide, the business began its journey to success as a small lab in 1983, which slowly grew over time. Since then, the company maintains its main goal, and that is to produce drugs that promote the health of companion animals, such as dogs, cats, and horses, as well as food-producing animals, such as pork and chickens. To ensure legal responsibility, the company’s manufacturing process is examined by the United States Food and Drug Administration (FDA). Med-Pharmex works closely with veterinary clinics who purchase their life-saving drugs and represent them in the market. Despite manufacturing drugs, the
Abramsons points are well taken, and it truly is a shame that the medical industry has become a business. In my opinion, if the pharmaceutical industry was taken out of the hands of the capitalist marketplace and given the to the government, it would become less of a business. Prescription drugs are not ordinary consumer goods; they are products that can ultimately save lives. If a money-oriented company controls these products, it is inevitable selling the drug would become a greater priority than actually creating a beneficial drug. Which as a result, will to the creation many well-marketed yet ineffective
In some instances, the pharmaceutical industry in the United States misleads both the public and medical professionals by participating in acts of both deceptive marketing practices and bribery, and therefore does not act within the best interests of the consumers. In America today, many people are in need of medical help. In fact,the Federal Trade Commission estimates that 75% of the population complain of physical problems (Federal Trade Commission 9). They complain, for example, of fatigue, colds, headaches, and countless other "ailments." When these symptoms strike, 65% purchase over-the-counter, or OTC, drugs.
Why do consumers purchase specific drugs for various ailments, sicknesses or diseases they might have? Why do physicians prescribe certain drugs over competitive drugs that may be available to the public? Why is it that most of us can easily name specific drugs that fit the many ailments of today’s society? On the surface the answer might be as simple as good TV advertising or radio commercials or even internet adds. The truth of matter is the major pharmaceutical manufacturers own the patents on these drugs and this gives them all of the marketing budget and muscle they need to promote the drug and control the pricing. The incentives for larger pharmaceutical companies are very enticing and as a result, they don’t mind spending the time in clinical trials and patent courts to get their drugs approved. Some will even get patents on the process by which the drug is manufactured, ensuring that no competitor can steal the drug or the process. This protects their large financial investment and nearly guarantees a large return for their investors. Many consumer rights groups claim this is nothing more than legalizing monopolies for the biggest manufacturers.
In conclusion, pharmaceutical companies are extremely edacious and cold-blooded. Their profits numbers in the billion’s range while seniors are struggling to afford their prescribed drugs to survive. The pharmaceutical industry is strongly against Americans getting their prescriptions from Canada. Yet these people cannot help it; they are not financially secure to afford the drugs sold in America. The U.S. Government tries to isolate itself from the problem in order to make money from the taxes of prescriptions. However, almost every other country has some type of control over their pharmaceutical companies’ prices. In the future, with more and more drugs developed, only more and more money is going to be in need by the pharmaceutical industry. So unless something can be done soon, this war on drugs is only going to climb uphill. Yet how could these top-paid personnel understand what it feels like to be unable to afford prescription drugs in order to maintain a healthy body or even to stay alive? If there was an answer to that question, the dilemma of overpriced drugs might have a solution.
Something is wrong with the focus on the "drug war" when 200,000 people die each year from prescription drugs, yet only 20,000 die from illegal drug use. Adverse reactions of prescription drugs are the third leading cause of death in America. In fact, people have a seven times greater chance of dying walking into their doctor's office than they do getting behind the wheel of their car! Every year approximately 200,000 souls die from prescription drug reactions with another 80,000 dying from medical malpractice (The International). Where is the FDA? Why do they continue to allow doctors to prescribe these drugs? How could they let it get to this point? What once was believed to be a panacia for depression has turned into Pandora's box (Tracy).
Government factors into the equation of the argument. Critics of the drug industry say that there is not enough regulation, while supporters of the pharmaceutical companies argue that there is too much regulation and that that is one...
However, despite it’s large role, surprisingly, the FDA is largely funded by user fees, which are fees that corporations pay to get their products reviewed for approval. This creates the interesting scenario where the FDA is receiving funding from the people they’re supposed to be facilitating — and therefore are incentivized to get (and accept) more applications. Although since the allowance of user fees, FDA’s resources and efficiency have dramatically increased, the same cannot be said for the quality of the checks. Since the FDA has allowed funding from user fees, there has been an increase in the approval of new drug applications, “from 38% in 2005 to 61% in 2018.” With this heightened approval rate, we also see a heightened recall rate as “before the user fee act was approved, 21% of medications were removed or had new black box warnings as compared to 27% afterwards.”
This means that medicines are ambiguous resulting in complex health policy. This leaves the citizens of US in dark due to increasing high cost and unknown of the pricing schedules. This leaves US in high percentage of increasing frauds daily. Citizens do not know what exactly is the cost of procedures; medicines and treatments, what the physician and the pharmacist ask they pay just to secure their life. This in return makes the chances of fraud type vulnerable act increased. On the other hand, patient trust on the doctor’s for the payment and is not even aware where the money is been used. This also increases the chance of fraud in US(Fisher,
d) For this scenario you are a community pharmacist and wish to begin dispensing clozapine for one of your patients presenting with a PBS Authority for clozapine. What steps will you need to take prior to dispensing the clozapine for the patient?
In current world the medical practitioners faces a lot of ethical dilemmas. According to ASHP foundation forecast, (2016-2020), the dilemmas are brought by technology advancements and shifting pharmaceutical marketplace dynamics. Thus seems there is the theory that explains tension between population healthcare and personal health care and overpricing of the medicine. This is due to lack transparency during the drug pricing decisions and though the united States have commenced investigations with the intentions to intervene, this problem does not seem to end in the near future. This overpricing may prevent all the patients getting the medicines. Pharmacists are also faced with the problem of reconciling advice and protocols on population-based with those on individual patients. Manufacturers and suppliers bear the responsibility to
In recent years’ health reform has been a driving force in the United States political system. If you watch the news, you will understand how citizens, the government, or the economy are or might be affected by some sort of change in medical regulation. One of these hot topic issues is the cost of prescription drugs. Every major drug market besides the United States regulates the price of drugs in some way (Abbott and Vernon). By the United States not doing so, many believe it opens consumers up to being exploited by large pharmaceutical companies.
With the increased cost of manufacturing, pharmaceutical companies have been divesting in their smaller or less profit making operations and focus on large segments. Many Pharmaceutical companies sold their manufacturing sites to contract manufacturing organizations. The dynamics of interfacing with contract manufacturing organization added intricacy in pharmaceutical supply chain network of pharmaceutical companies.
The case under analysis, Eli Lilly & Company, will be covering the positives and negatives with regards to the business situation and strategy of Eli Lilly. One of the major pharmaceutical and health care companies in its industry, Lilly focused its efforts on the areas of "drug research, development, and marketed to the following areas: neuroscience, endocrinology, oncology, cardiovascular disease, and women's health." Having made a strong comeback in the 1990's due to its remarkably successful antidepressant Prozac, was now facing a potential loss in profits with its patent soon to expire. The problem was not only the soon to expire patent on Prozac, but the fact that Prozac accounted for as much as 30% of total revenue was the reality Eli Lilly now faced. (Pearce & Robinson, 34-1)
The validation of medicine has been an issue in politics for a long time. Many people think that the validation of drugs will give the government more control and there will be less crime on the streets. Another issue is that the government will be able to profit money off the drugs and be able to control prices and what age you will have to be to be able to buy the drug.